<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.jbc.org/content/279/9/7792.full">
<meta name="wpd_url" content="http://www.jbc.org/content/279/9/7792.full">
<meta name="wpd_date" content="2013-04-10T16:11Z">

      
      <title>Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway </title>
      <meta name="googlebot" content="NOODP">
      <meta name="HW.ad-path" content="/cgi/content/full/279/9/7792">
      <meta content="/jbc/279/9/7792.atom" name="HW.identifier">
      <meta name="DC.Format" content="text/html">
      <meta name="DC.Language" content="en">
      <meta content="Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway" name="DC.Title">
      <meta content="10.1074/jbc.M313093200" name="DC.Identifier">
      <meta content="2004-02-27" name="DC.Date">
      <meta content="American Society for Biochemistry and Molecular Biology" name="DC.Publisher">
      <meta content="Andrew Mehle" name="DC.Contributor">
      <meta content="Bettina Strack" name="DC.Contributor">
      <meta content="Petronela Ancuta" name="DC.Contributor">
      <meta content="Chengsheng Zhang" name="DC.Contributor">
      <meta content="Mark McPike" name="DC.Contributor">
      <meta content="Dana Gabuzda" name="DC.Contributor">
      <meta content="Journal of Biological Chemistry" name="citation_journal_title">
      <meta content="J. Biol. Chem." name="citation_journal_abbrev">
      <meta content="0021-9258" name="citation_issn">
      <meta content="1083-351X" name="citation_issn">
      <meta name="citation_author" content="Andrew Mehle">
      <meta name="citation_author" content="Bettina Strack">
      <meta name="citation_author" content="Petronela Ancuta">
      <meta name="citation_author" content="Chengsheng Zhang">
      <meta name="citation_author" content="Mark McPike">
      <meta name="citation_author" content="Dana Gabuzda">
      <meta content="Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway" name="citation_title">
      <meta content="02/27/2004" name="citation_date">
      <meta content="279" name="citation_volume">
      <meta content="9" name="citation_issue">
      <meta content="7792" name="citation_firstpage">
      <meta content="7798" name="citation_lastpage">
      <meta content="279/9/7792" name="citation_id">
      <meta content="jbc;279/9/7792" name="citation_mjid">
      <meta content="10.1074/jbc.M313093200" name="citation_doi">
      <meta content="http://www.jbc.org/content/279/9/7792.abstract" name="citation_abstract_html_url">
      <meta content="http://www.jbc.org/content/279/9/7792.full" name="citation_fulltext_html_url">
      <meta content="http://www.jbc.org/content/279/9/7792.full.pdf" name="citation_pdf_url">
      <meta content="http://www.jbc.org/content/279/9/7792" name="citation_public_url">
      <meta content="14672928" name="citation_pmid">
      <meta name="citation_section" content="Protein Synthesis, Post-Translation Modification, and Degradation">
      <meta name="robots" content="noarchive,nofollow">
      <meta name="googlebot" content="noarchive">
      <link href="http://www.jbc.org/content/279/9/7785.short" rel="prev">
      <link href="http://www.jbc.org/content/279/9/7799.short" rel="next">
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      <script type="text/javascript" id="session-d124562192e1">var callbackToken='46213D11FB7564F';</script><script type="text/javascript" src="jquery-min.js"></script><script type="text/javascript" src="hw-shared.js"></script><script type="text/javascript" src="hw-design1.js"></script><script type="text/javascript" src="hw-publisher-shared.js"></script><script type="text/javascript" src="oas_advertising.js"></script><script type="text/javascript" src="hw-content.js"></script><script type="text/javascript" src="AccessCheckLib.js"></script><script type="text/javascript" src="executeAccessCheck.js"></script><script type="text/javascript" src="jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="jquery.easing-1.3.pack.js"></script><script type="text/javascript" src="jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="content.jquery.addVariantLink.js"></script><script type="text/javascript" src="hw-col-expand.js"></script>
<link rel="stylesheet" type="text/css" href="7792.css" media="all">
</head>
<body>
      <div class="hw-gen-page pagetype-content" id="pageid-content" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
         <div id="header">      
            <a href="http://www.jbc.org/"><img title="The Journal of Biological Chemistry" alt="The Journal of Biological Chemistry" id="main-logo" src="journal_logo.gif"></a>
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="http://www.jbc.org/" title="Home"><span>Home</span></a></li>
               <li><a href="http://www.jbc.org/content/current" title="Current issue"><span>Current issue</span></a></li>
               <li><a href="http://www.jbc.org/content/by/year" title="Archive"><span>Archive</span></a></li>
               <li><a href="http://www.jbc.org/content/early/recent/0" title="Papers in Press"><span>Papers in Press</span></a></li>
               <li id="minireviews"><a href="http://www.jbc.org/content/by/section/Minireviews" title="Minireviews"><span>Minireviews</span></a></li>
               <li id="reports"><a href="http://www.jbc.org/content/by/section/Reports" title="Reports"><span>Reports</span></a></li>
               <li id="classics"><a href="http://www.jbc.org/content/by/section/Classics" title="Classics"><span>Classics</span></a></li>
               <li id="reflections"><a href="http://www.jbc.org/content/by/section/Reflections" title="Reflections"><span>Reflections</span></a></li>
               <li id="potw" class="last"><a href="http://www.jbc.org/potw" title="Papers of the Week"><span>Papers of the Week</span></a></li>
            </ul>
            
            <div class="header-qs">
               
               <form class="searchbox" action="http://www.jbc.org/search" method="get"><span class="searchform-label">QUICK SEARCH</span><label for="header-qs-input-author">Author:</label><input name="author1" id="header-qs-input-author" size="9" type="text"><label for="header-qs-input-keyword">Keyword:</label><input name="fulltext" id="header-qs-input-keyword" size="16" type="text"><label for="header-qs-input-year">Year:</label><input name="pubdate_year" id="header-qs-input-year" size="4" type="text"><label for="header-qs-input-vol">Vol:</label><input name="volume" id="header-qs-input-vol" size="4" type="text"><label for="header-qs-input-page">Page:</label><input name="firstpage" id="header-qs-input-page" size="4" type="text"><input name="submit" value="yes" type="hidden"><label for="header-qs-search-go" id="header-qs-search-label">GO</label><input alt="Link: Go" value="Go" id="header-qs-search-go" type="submit"><span class="adv-search-link"><a href="http://www.jbc.org/search">[Advanced Search]</a></span><span class="adv-search-link"><a href="http://www.jbc.org/content/by/year">[Browse the Archive]</a></span></form>
               
               
            </div>
            
            <div class="header-ac-elements">
               
               <div class="inst-branding">
                  
               </div>
               
               <div id="authstring" class="suppress-header-login">
                  
                  
               </div> 
               
               
               <div id="hdr-login" class="suppress-header-login"></div>
               
            </div>
            
            <div id="ad-top">
               <span class="ad-header">Advertisement</span>
               <script type="text/javascript">

      OAS_AD('Top');
    </script>
               </div>
            
            <div id="ad-top2">
               <span class="ad-header">Advertisement</span>
               
               <ul>
                  <li><a href="http://www.jbc.org/cgi/adclick/?ad=37401&amp;adclick=true&amp;url=http%3A%2F%2Fwww.chempep.com%2F" target="_top"><img class="adborder0" title="ChemPep" src="ChemPep_Banner.gif" alt="ChemPep"></a></li>
               </ul>
               
            </div>
            
         </div>
         <div style="height: auto;" id="content-block"><div id="content-option-box" title="Expand this column"><ul><li id="content-toggle"><a href="#"><span class="descr">Expand</span><span>+</span></a></li></ul></div><div id="print-slug" class="print-only"><span class="jnl-title">Journal of Biological Chemistry</span><span class="jnl-url">www.jbc.org</span><div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              		<span class="slug-metadata-note ahead-of-print">

                                 	
                                 First Published on
                                 
                                 <span class="slug-ahead-of-print-date">December 13, 2003</span>,
                                 doi:
                                 <span title="10.1074/jbc.M313093200" class="slug-doi">10.1074/jbc.M313093200
                                    </span>
                                 </span>
                              
                              <cite>
                                 	    <span class="slug-pub-date" itemprop="datePublished">

                                    	    February 27, 2004 
                                    </span><abbr title="The Journal of Biological Chemistry" class="slug-jnl-abbrev">

                                    The Journal of Biological Chemistry,</abbr>
                                 	    <span class="slug-vol">

                                    279, 
                                    </span><span class="slug-pages">

                                    7792-7798.
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div></div><img src="hwp-legacy-fpage.png" class="article-logo hwp-legacy-fpage"><div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway<a id="xref-fn-3-1" class="xref-fn" href="#fn-3">*</a></h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jbc.org/search?author1=Andrew+Mehle&amp;sortspec=date&amp;submit=Submit">Andrew Mehle</a></span><a id="xref-target-1-1" class="xref-other" href="#target-1">‡</a><a id="xref-target-2-1" class="xref-other" href="#target-2">§</a><a id="xref-fn-4-1" class="xref-fn" href="#fn-4">¶</a>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jbc.org/search?author1=Bettina+Strack&amp;sortspec=date&amp;submit=Submit">Bettina Strack</a></span><a id="xref-target-1-2" class="xref-other" href="#target-1">‡</a><a id="xref-target-2-2" class="xref-other" href="#target-2">§</a>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jbc.org/search?author1=Petronela+Ancuta&amp;sortspec=date&amp;submit=Submit">Petronela Ancuta</a></span><a id="xref-target-1-3" class="xref-other" href="#target-1">‡</a><a id="xref-target-2-3" class="xref-other" href="#target-2">§</a>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jbc.org/search?author1=Chengsheng+Zhang&amp;sortspec=date&amp;submit=Submit">Chengsheng Zhang</a></span><a id="xref-target-1-4" class="xref-other" href="#target-1">‡</a><a id="xref-target-2-4" class="xref-other" href="#target-2">§</a>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://www.jbc.org/search?author1=Mark+McPike&amp;sortspec=date&amp;submit=Submit">Mark McPike</a></span><a id="xref-target-1-5" class="xref-other" href="#target-1">‡</a><a id="xref-target-2-5" class="xref-other" href="#target-2">§</a> and 
                     </li>
                     <li class="last" id="contrib-6"><span class="name"><a class="name-search" href="http://www.jbc.org/search?author1=Dana+Gabuzda&amp;sortspec=date&amp;submit=Submit">Dana Gabuzda</a></span><a id="xref-target-1-6" class="xref-other" href="#target-1">‡</a><a id="xref-target-3-1" class="xref-other" href="#target-3">∥</a><span class="xref-sep">,</span><a id="xref-corresp-1-1" class="xref-corresp" href="#corresp-1">**</a></li>
                  </ol><p class="affiliation-list-reveal"><a href="#" class="view-more">+</a> Author Affiliations</p>
                  <ol class="affiliation-list hideaffil">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><a id="target-1"></a><sup>‡</sup>Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 and Departments of <a id="target-2"></a><sup>§</sup>Pathology and <a id="target-3"></a><sup>∥</sup>Neurology, Harvard Medical School, Boston, Massachusetts 02115
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><a class="rev-xref" href="#xref-corresp-1-1">↵</a><span class="corresp-label">**</span> To whom correspondence should be addressed: Dana-Farber Cancer Institute, JF816, 44 Binney St., Boston, MA 02115. Tel.: 617-632-2154;
                        Fax: 617-632-3113; E-mail: <a href="mailto:dana_gabuzda@dfci.harvard.edu">dana_gabuzda@dfci.harvard.edu</a>. 
                     </li>
                  </ol>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder">&nbsp;</div><a href="#sec-1" title="Next Section" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  <p id="p-1">Viruses must overcome diverse intracellular defense mechanisms to establish infection. The Vif (virion infectivity factor)
                     protein of human immunodeficiency virus 1 (HIV-1) acts by overcoming the antiviral activity of APOBEC3G (CEM15), a cytidine
                     deaminase that induces G to A hypermutation in newly synthesized viral DNA. In the absence of Vif, APOBEC3G incorporation
                     into virions renders HIV-1 non-infectious. We report here that Vif counteracts the antiviral activity of APOBEC3G by targeting
                     it for destruction by the ubiquitin-proteasome pathway. Vif forms a complex with APOBEC3G and enhances APOBEC3G ubiquitination,
                     resulting in reduced steady-state APOBEC3G levels and a decrease in protein half-life. Furthermore, Vif-dependent degradation
                     of APOBEC3G is blocked by proteasome inhibitors or ubiquitin mutant K48R. A mutation of highly conserved cysteines or the
                     deletion of a conserved SLQ(Y/F)LA motif in Vif results in mutants that fail to induce APOBEC3G degradation and produce non-infectious
                     HIV-1; however, mutations of conserved phosphorylation sites in Vif that impair viral replication do not affect APOBEC3G degradation,
                     suggesting that Vif is important for other functions in addition to inducing proteasomal degradation of APOBEC3G. Vif is monoubiquitinated
                     in the absence of APOBEC3G but is polyubiquitinated and rapidly degraded when APOBEC3G is coexpressed, suggesting that coexpression
                     accelerates the degradation of both proteins. These results suggest that Vif functions by targeting APOBEC3G for degradation
                     via the ubiquitin-proteasome pathway and implicate the proteasome as a site of dynamic interplay between microbial and cellular
                     defenses.
                  </p>
               </div>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-2" title="EXPERIMENTAL PROCEDURES" class="next-section-link"><span>Next Section</span></a></div>
                  <p id="p-2">Human immunodeficiency virus 1 (HIV-1)<sup><a id="xref-fn-1-1" class="xref-fn" href="#fn-1">1</a></sup> and other lentiviruses encode the <em>vif</em> (<span class="underline">v</span>irion <span class="underline">i</span>nfectivity <span class="underline">f</span>actor) gene, which is essential for the production of infectious virus (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>). Recent studies demonstrate that Vif counteracts the innate antiviral activity of APOBEC3G, also known as CEM15 (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>–<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>). APOBEC3G, a member of the APOBEC family of cytidine deaminase-editing enzymes, is a potent DNA mutator that can be packaged
                     into budding retroviruses (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>, <a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>). After the initiation of reverse transcription, APOBEC3G edits minus-stranded viral cDNA, converting cytosine to uracil
                     and affecting the stability and fidelity of newly synthesized cDNA (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>–<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">8</a>). These mutations may initiate a DNA base excision repair pathway that compromises the structural integrity of the single-stranded
                     viral DNA, resulting in the catastrophic failure of reverse transcription characteristic of Vif-defective (ΔVif) viruses (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>). Furthermore, the massive C to U conversion in the minus strand leads to G to A hypermutation in the viral genome, which
                     affects subsequent stages of the viral life cycle and decreases viral fitness (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>, <a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">8</a>). Thus, APOBEC3G editing likely contributes to sequence variation within viral populations, particularly the G to A mutational
                     bias characteristic of HIV-1 (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>).
                  </p>
                  <p id="p-3"></p>
                  <p id="p-5">Vif is required in virus-producing cells during the late stages of infection (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). Replication in “non-permissive” cells, such as primary T lymphocytes, macrophages, and certain T cell lines, is strictly
                     dependent on Vif, whereas Vif is dispensable for replication in “permissive” cell lines, such as 293T cells (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). APOBEC3G expression is restricted to non-permissive cells (<a id="xref-ref-3-3" class="xref-bibr" href="#ref-3">3</a>), whereas its expression in permissive cells confers a non-permissive phenotype (<a id="xref-ref-3-4" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-6-3" class="xref-bibr" href="#ref-6">6</a>–<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>). In non-permissive cells, Δ<em>vif</em> viruses can produce virions, but they fail to complete reverse transcription and cannot establish infection (<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>). The expression of Vif in <em>trans</em> in virus-producing cells but not target cells rescues this defect (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>). Vif forms a complex with APOBEC3G, preventing its viral encapsidation, and thereby protects the viral genome from editing
                     mutations (<a id="xref-ref-8-5" class="xref-bibr" href="#ref-8">8</a>). The interaction between Vif and APOBEC3G is species-specific (<a id="xref-ref-8-6" class="xref-bibr" href="#ref-8">8</a>), which may play a role in restricting the replication of HIV-1 to humans.
                  </p>
                  <p id="p-6">The mechanism by which Vif inhibits APOBEC3G encapsidation into HIV-1 is unclear. In this study we demonstrate that Vif counteracts
                     the antiviral activity of APOBE3G by promoting the ubiquitination and proteasomal degradation of APOBE3G. By destabilizing
                     APOBEC3G, Vif enhances viral infectivity, suggesting that the primary function of Vif is to target APOBEC3G for destruction.
                     APOBEC3G also promotes polyubiquitination and degradation of Vif, suggesting a reciprocal relationship wherein coexpression
                     accelerates the degradation of both proteins. These results suggest that Vif has evolved to target APOBEC3G for degradation
                     and implicate the ubiquitin-proteasome pathway in the dynamic interplay of microbial and host defenses.
                  </p>
               </div>
               <div class="section" id="sec-2">
                  <div class="section-nav"><a href="#sec-1" title="Previous Section" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-3" title="RESULTS" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>EXPERIMENTAL PROCEDURES</h2>
                  <p id="p-7"><em>Antibodies and Plasmids—</em>Antibodies used were rabbit anti-Vif (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>), rat 3F10 anti-HA (Roche Applied Science), mouse M2 anti-FLAG (Sigma), mouse 9E10 anti-myc (Roche Applied Science), mouse
                     anti-tubulin (Sigma), and rabbit anti-APOBEC3G (a gift of Greene and co-workers (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>)). The HIV-1 NL4–3 proviral plasmid pNLX (pNL4–3/XmaI) has been described previously (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>). pNLXΔVif was created by exchanging the ApaI-EcoRI fragment from NL4–3ΔVif (<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>). HIV-1 HXB2 proviral plasmids containing the Vif mutants T96A, S144A, and T188A have been previously described (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). pAPOBEC3G:HA was a gift of M. Malim (<a id="xref-ref-3-5" class="xref-bibr" href="#ref-3">3</a>). Epitope-tagged Vif was expressed from pNLA1.Vif-FLAG (gift of K. Strebel). Wild-type (WT) and mutant Vif expression plasmids
                     were created in pCDNA1 (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>). Ub, Ub<sub>K48R</sub>, and HA-Ub were a gift of H. Gottlinger. mycUb and mycUb<sub>K48R</sub> were encoded by pRbG4-His<sub>6</sub>-myc-Ub (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>).
                  </p>
                  <p id="p-8"><em>Immunoprecipitation and Western Blot Analysis—</em>Hut78 cells and the Hut78-Vif cell line that stably expresses Vif were maintained in RPMI medium with 10% fetal bovine serum
                     or in the same medium with 0.5 μg/ml puromycin, respectively. 293T cells were cultured in Dulbecco's modified Eagle's medium
                     with 10% fetal bovine serum and transfected by calcium phosphate with 20 μg of DNA or LipofectAMINE 2000 (<a title="[opens in a new window]" target="_top" href="http://www.jbc.org/cgi/redirect-inline?ad=Invitrogen" class="inline-ad-match" rel="external-nw">Invitrogen</a>) with 4 μg of DNA. For Western blotting, lysates were prepared 36–48 h post-transfection in a lysis buffer (50 m<span class="sc">m</span> Tris-HCl (pH 7.2), 150 m<span class="sc">m</span> NaCl, 10% glycerol, 0.5% Cymal-5, and 1% protease inhibitor mixture (Sigma)). Inhibitors were applied to cells for 6 h before
                     lysis using the following conditions; MG132 (Peptide Intl.) and <em>clasto</em>-lactacystin β-lactone (Boston Biochem) at 50 and 10 μ<span class="sc">m</span>, respectively, and chloroquine (Sigma) at 200 μ<span class="sc">m</span>. Identical amounts of protein were separated by SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and detected
                     by standard techniques. Where indicated, identical amounts of lysate were subjected to immunoprecipitation followed by Western
                     blotting. Co-immunoprecipitations were performed with cells lysed in a detergent buffer (0.5% Nonidet P-40, 50 m<span class="sc">m</span> Tris-HCl (pH 7.4), 150 m<span class="sc">m</span> NaCl, and a 1% protease inhibitor mixture (Sigma)). <em>In vitro</em> binding studies were performed with GST-Vif purified from bacteria and recombinant APOBEC3G (provided by Immuno-Diagnostics,
                     Inc.). After washing, protein complexes were analyzed by Western blotting. Pulse-chase experiments were performed in 293T
                     cells transfected with pNLX alone (15 μg), pNLXΔVif (15 μg) and pAPOBEC3G:HA (0.1 μg), or pNLX (15 μg) and pAPOBEC3G:HA (0.1
                     μg) adjusted to 20 μg total with an empty vector. Cells were starved for 30 min in Met-Cys-Dulbecco's modified Eagle's medium,
                     labeled for 20 min with 50 μCi/ml [<sup>35</sup>S]methionine and [<sup>35</sup>S]cysteine, and chased using 20 m<span class="sc">m</span> unlabeled <span class="sc">l</span>-methionine and <span class="sc">l</span>-cysteine. Cells were lysed in radioimmune precipitation assay buffer and quantitated by the detergent-compatible protein
                     assay (Bio-Rad). Identical amounts of lysate were subjected to immunoprecipitation, resolved by SDS-PAGE, and analyzed by
                     phosphorimaging. Half-life was calculated by modeling exponential decay for early phase degradation of APOBEC3G (0–45 min)
                     or all time points for Vif (0–60 min).
                  </p>
                  <p id="p-9"><em>Viruses and Infections—</em>Virus was produced from 293T cells transfected with proviral plasmids. Viruses were quantitated by reverse transcriptase assays,
                     and similar amounts were used to infect the reporter cell line Cf2-luc (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>). Infection was measured 48 h after infection by performing luciferase assays (Promega). Infections of H9 or SupT1 cells
                     were initiated by co-culture with virus-producing 293T cells (<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>). After overnight incubation, H9 or SupT1 cells were removed, washed, and cultured in RPMI medium with 10% fetal bovine serum.
                  </p>
                  <p id="p-10"><em>Semiquantitative Reverse Transcriptase PCR—</em>Reverse transcriptase PCR was performed as described (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>) using total mRNA (1 μg) isolated from infected or uninfected H9 and SupT1 cells collected 5 days after infection. The primers
                     used were APOBEC3G forward 5′-AAT AGA CCC ATC CTT TCT CGT CGG AAT ACC-3′ and reverse 5′-GTT CAG CAG GAC CCA GGT GTC ATT G-3′.
                  </p>
               </div>
               <div class="section" id="sec-3">
                  <div class="section-nav"><a href="#sec-2" title="EXPERIMENTAL PROCEDURES" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-4" title="DISCUSSION" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>RESULTS</h2>
                  <p id="p-11"><em>Vif Reduces Steady-state Levels of APOBEC3G—</em>As an initial approach to investigate how Vif counteracts the antiviral activity of APOBEC3G, we examined the effect of Vif
                     on APOBEC3G expression. HA-tagged APOBEC3G was expressed in 293T cells, which do not express APOBEC3G endogenously (<a id="xref-ref-3-6" class="xref-bibr" href="#ref-3">3</a>). The 46-kDa HA-tagged APOBEC3G protein, in addition to minor 22- and 24-kDa species that may represent proteolytic degradation
                     fragments of APOBEC3G, were detected by Western blotting (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>). In the presence of Vif, the steady-state levels of APOBEC3G were markedly decreased (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>). Similarly, endogenous APOBEC3G was depleted in a Hut78 cell line that stably expresses Vif (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Fig. 1<em>B</em></a>). Co-transfection of increasing amounts of pNLA1.Vif-FLAG together with a constant amount of pAPOBEC3G:HA showed that Vif
                     expression reduced APOBEC3G levels in a dose-dependent manner (<a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1<em>C</em></a>). This effect was specific for APOBEC3G because levels of the control protein tubulin were unchanged (<a id="xref-fig-1-5" class="xref-fig" href="#F1">Fig. 1<em>C</em></a>). A critical Vif:APOBEC3G ratio was required for the reduction of APOBEC3G levels (<a id="xref-fig-1-6" class="xref-fig" href="#F1">Fig. 1<em>C</em></a>, <em>lanes 5</em> and <em>6</em>). At lower Vif: APOBEC3G ratios, Vif had no detectable effect on APOBEC3G levels (<a id="xref-fig-1-7" class="xref-fig" href="#F1">Fig. 1<em>C</em></a>, <em>lanes 2–4</em>). Most subsequent experiments were therefore performed under conditions in which APOBEC3G levels were expected to be limiting.
                     We then used loss-of-function Vif mutants to further explore the effect of Vif on APOBEC3G levels. The highly conserved cysteine
                     residues at positions 114 and 133 and SLQ(Y/F)LA motif at residues 144–149 are required for Vif function and HIV-1 replication
                     (<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>). Thr<sup>96</sup>, Ser<sup>144</sup>, and Thr<sup>188</sup> are highly conserved phosphorylation sites in Vif. Mutation of Thr<sup>96</sup> or Ser<sup>144</sup> impairs but does not abolish viral replication (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>, <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>). In contrast to wild-type Vif, Vif<sub>C114S/C133S</sub> and the VifΔ142–154 mutant that removes the SLQ(Y/F)LA motif showed a markedly reduced ability to decrease APOBEC3G levels
                     (<a id="xref-fig-1-8" class="xref-fig" href="#F1">Fig. 1<em>D</em></a>), suggesting a relationship between the ability of Vif to reduce APOBEC3G levels and to support virus replication. However,
                     the T96A, S144A, and T188A mutants retained the ability to decrease APOBEC3G levels (<a id="xref-fig-1-9" class="xref-fig" href="#F1">Fig. 1<em>D</em></a>). Thus, some mutations that reduce Vif function during viral replication still have the wild-type ability to decrease APOBEC3G
                     levels. We then investigated whether Vif affects APOBEC3G mRNA levels in H9 cells infected with wild-type and <em>vif</em>-deficient HIV-1 by reverse transcriptase PCR (<a id="xref-fig-1-10" class="xref-fig" href="#F1">Fig. 1<em>E</em></a>). APOBEC3G mRNA levels were unaffected by the presence of Vif. Furthermore, infection of H9 cells with either virus did not
                     appear to increase APOBEC3G mRNA levels compared with uninfected cells. Thus, Vif did not alter APOBEC3G mRNA levels, suggesting
                     that Vif decreases APOBEC3G protein levels at a post-translational step.
                  </p>
                  <div id="F1" class="fig pos-float odd">
                     <div class="fig-inline"><a href="http://www.jbc.org/content/279/9/7792/F1.expansion.html"><img alt="Fig. 1." src="F1.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="http://www.jbc.org/content/279/9/7792/F1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="http://www.jbc.org/content/279/9/7792/F1.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="http://www.jbc.org/powerpoint/279/9/7792/F1">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">F<span class="sc">ig</span>. 1.</span> 
                        <p id="p-13" class="first-child"><strong>Vif reduces steady-state levels of APOBEC3G.</strong> <em>A</em>, APOBEC3G:HA and Vif-FLAG were expressed in 293T cells by transfection with 10 μg of pNLA1.Vif-FLAG and/or 0.5 μg of pAPOBEC3G:HA
                           equalized to 20 μg of total DNA with an empty vector. Lysates were subjected to immunoprecipitation with anti-HA or anti-FLAG
                           antibodies followed by Western blot analysis. The <em>right panel s</em>hows a longer exposure of the <em>middle panel</em>. The size of protein molecular weight markers (in kilodaltons) is shown on the <em>left. B</em>, Vif, endogenous APOBEC3G, and tubulin were detected by Western blot in lysates prepared from Hut78 cells, a Hut78-Vif cell
                           line that stably expresses Vif, or the APOBEC3G-negative cell line SupT1. <em>C</em>, 293T cells were transfected as in <em>A</em> with 0.05 μg of pAPOBEC3G:HA and increasing amounts of Vif expression plasmid (0, 0.1, 0.2, 0.5, 1.0, or 2.0 μg). Lysates
                           were subjected to Western blot analysis using anti-HA or anti-Vif antibodies. <em>D</em>, Western blot analysis of APOBEC3G coexpressed with WT Vif or Vif<sub>C114S/C133S</sub>. 19.5 μg of pCDNA1.Vif or pCDNA1.Vif C114S/C133S, or Δ142–154 were co-transfected with 0.5 μg of pAPOBEC3G:HA. Vif phosphorylation
                           site mutants were expressed by co-transfecting 15 μg of proviral plasmid with 0.1 μg of pAPOBEC3G:HA. A background band is
                           indicated by an <em>asterisk. E</em>, expression of APOBEC3G mRNA is shown in infected and uninfected H9 cells. Reverse transcriptase PCR was performed as described
                           under “Experimental Procedures” using primers that detect APOBEC3G and β<sub>2</sub>-microglobulin. SupT1 cells were included as a negative control.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <p id="p-12"></p>
                  <p id="p-14"><em>Vif Accelerates Degradation of APOBEC3G by the Ubiquitin-Proteasome Pathway—</em>The preceding experiments suggested that Vif might reduce APOBEC3G levels by promoting its degradation. Intracellular protein
                     stability is regulated by lysosomal or proteasome-mediated degradation (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). The ubiquitin-proteasome pathway involves the ubiquitination of target proteins and subsequent degradation by the 26 S
                     proteasome. The presence of high molecular mass species of APOBEC3G at ∼54 and 60 kDa (<a id="xref-fig-1-11" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>) raised the possibility that it is covalently modified by ubiquitin. The proteasome inhibitors MG132 and <em>clasto</em>-lactacystine β-lactone in combination markedly reduced the ability of Vif to induce the degradation of APOBEC3G (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2<em>A</em></a>). Similar results were observed over a range of proteasome inhibitor concentrations and combinations.<sup><a id="xref-fn-2-1" class="xref-fn" href="#fn-2">2</a></sup> In contrast, the lysosome inhibitor chloroquine had no effect on APOBEC3G stability (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2<em>C</em></a>). The expression of APOBEC3G in the presence of myc-tagged ubiquitin resulted in a shift of the higher molecular weight species
                     of APOBEC3G, suggesting that APOBEC3G is ubiquitinated.<sup><a id="xref-fn-2-2" class="xref-fn" href="#fn-2">2</a></sup> This was confirmed by Western blot analysis of immunoprecipitated APOBEC3G with anti-myc antibody, which showed a high molecular
                     weight smear typical of polyubiquitination (<a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2<em>B</em></a>, <em>top</em>). Coexpression of Vif dramatically increased polyubiquitination of APOBEC3G (<a id="xref-fig-2-4" class="xref-fig" href="#F2">Fig. 2<em>B</em></a>, <em>top</em>). The effect of Vif on APOBEC3G ubiquitination was most readily detected at high APOBEC3G expression levels (<a id="xref-fig-2-5" class="xref-fig" href="#F2">Fig. 2<em>B</em></a>, <em>middle</em>). However, APOBEC3G ubiquitination was also observed at lower levels of APOBEC3G expression that are destabilized by Vif
                     (Figs. <a id="xref-fig-1-12" class="xref-fig" href="#F1">1<em>A</em></a> and <a id="xref-fig-2-6" class="xref-fig" href="#F2">2<em>A</em></a>). These findings indicate that Vif promotes the polyubiquitination and proteasome-mediated degradation of APOBEC3G.
                  </p>
                  <div id="F2" class="fig pos-float odd">
                     <div class="fig-inline"><a href="http://www.jbc.org/content/279/9/7792/F2.expansion.html"><img alt="Fig. 2." src="F2.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="http://www.jbc.org/content/279/9/7792/F2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="http://www.jbc.org/content/279/9/7792/F2.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="http://www.jbc.org/powerpoint/279/9/7792/F2">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">F<span class="sc">ig</span>. 2.</span> 
                        <p id="p-16" class="first-child"><strong>Vif promotes ubiquitin-dependent proteasomal degradation of APOBEC3G.</strong> <em>A</em>, Vif and APOBEC3G were expressed in 293T cells as in <a id="xref-fig-1-13" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>. Transfected cells were treated with MG132/β-lactone or Me<sub>2</sub>SO for 6 h prior to lysis and Western blotting. <em>B</em>, pNLA1.Vif-FLAG (10 μg), pAPOBEC3G:HA (5 μg), and pRbG4-His<sub>6</sub>-myc-Ub (5 μg) were co-transfected into 293T cells as indicated. DNA was equalized to 20 μg with an empty vector where needed.
                           APOBEC3G and Vif were immunoprecipitated and Western blotted as in <a id="xref-fig-1-14" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>. Anti-HA immunoprecipitates were probed with anti-myc to detect ubiquitinated APOBEC3G (<em>top</em>). Ubiquitinated species are indicated. <em>C</em>, 293T cells were transfected as in <em>B</em> with the indicated plasmids and treated with chloroquine or MG132/β-lactone for 6 h before lysis. APOBEC3G and Vif were detected
                           by Western blotting with anti-HA and anti-Vif antibodies, respectively. <em>D</em>, The half-life of APOBEC3G was analyzed by pulse-chase analysis of 293T cells transfected with pAPOBEC3G:HA and pNLX (♦)
                           or pNLXΔVif (▪) as described under “Experimental Procedures.” APOBEC3G was immunoprecipitated with anti-HA antibody and quantitated
                           by phosphorimaging analysis. Protein levels were normalized to <em>t</em><sub>0</sub> = 100%. Results are representative of four independent experiments.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <p id="p-15"></p>
                  <p id="p-17"></p>
                  <p id="p-19">Polyubiquitination typically results in proteolysis of the substrate protein via the proteasome. Treatment of cells with MG132/β-lactone
                     increased the levels of polyubiquitinated APOBEC3G, suggesting that APOBEC3G is rapidly degraded by the proteasome (<a id="xref-fig-2-7" class="xref-fig" href="#F2">Fig. 2<em>C</em></a>, <em>top</em>). This was further supported by experiments using the ubiquitin mutant K48R. Multiubiquitin chains linked via Lys<sup>48</sup> are the principal signals for proteasomal degradation (<a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a>). Ub<sub>K48R</sub> is a polyubiquitin chain terminator that reduces the efficiency of proteasome-mediated degradation and stabilizes polyubiquitinated
                     substrates (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>). When coexpressed with APOBEC3G and Vif, Ub<sub>K48R</sub> enhanced the accumulation of polyubiquitinated APOBEC3G (<a id="xref-fig-2-8" class="xref-fig" href="#F2">Fig. 2<em>C</em></a>, <em>top</em>). The accumulation of high molecular weight conjugates in the presence of Ub<sub>K48R</sub> suggests the attachment of ubiquitin to multiple sites within APOBEC3G and/or the incorporation of endogenous wild-type ubiquitin
                     into the mutant polyubiquitin chains. The accumulation of polyubiquitinated APOBEC3G is probably the consequence of disrupted
                     proteasomal targeting signals or the dynamic remodeling of polyubiquitin chains that occur in the presence of the K48R mutant
                     (<a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a>, <a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>). In contrast to the effects of proteasome inhibitors, chloroquine had no significant effect. The proteasome inhibitors and
                     ubiquitin mutants did not affect steady-state levels of APOBEC3G in the absence of Vif (<a id="xref-fig-2-9" class="xref-fig" href="#F2">Fig. 2<em>C</em></a>, <em>bottom</em>), suggesting that Vif accelerates the degradation of APOBEC3G by the ubiquitin-proteasome pathway.
                  </p>
                  <p id="p-20">Given that Vif decreases APOBEC3G levels and increases its ubiquitination, we investigated the effect of Vif on the half-life
                     of APOBEC3G in virus-producing cells. APOBEC3G was expressed with WT or ΔVif proviruses and analyzed by pulsechase metabolic
                     labeling. APOBEC3G displayed a biphasic decay characterized by rapid degradation in the early phase, followed by a slow decay
                     of a relatively stable APOBEC3G population during the late phase (<a id="xref-fig-2-10" class="xref-fig" href="#F2">Fig. 2<em>D</em></a>). The half-life of APOBEC3G during the early phase was significantly decreased from approximately 29 min in the absence of
                     Vif to 18 min in its presence. Proteasome inhibitors restored the half-life of APOBEC3G in the presence of WT virus to that
                     of APOBEC3G with ΔVif virus.<sup><a id="xref-fn-2-3" class="xref-fn" href="#fn-2">2</a></sup> The stable population of APOBEC3G detected during the late phase appeared to be unaffected by Vif, which may account for
                     the inability of Vif to induce complete degradation of APOBEC3G (<a id="xref-fig-1-15" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>). These results demonstrate two populations of APOBEC3G that differ in their susceptibility to down-modulation by Vif and
                     are degraded at different rates and suggest that Vif decreases the half-life of the susceptible population during early phase
                     decay by promoting its degradation via the ubiquitin-proteasome pathway.
                  </p>
                  <p id="p-21"><em>Vif and APOBEC3G Form a Complex—</em>We next investigated whether Vif interacts with APOBEC3G or promotes its degradation through an indirect mechanism. To determine
                     whether Vif and APOBEC3G interact in a complex, we performed reciprocal co-immunoprecipitation assays after expression of
                     Vif and/or HA-tagged APOBEC3G in 293T cells. A significant amount of APOBEC3G could be specifically co-immunoprecipitated
                     with an anti-Vif antibody (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Fig. 3<em>A</em></a>, <em>top</em>). In a reciprocal experiment, Vif was co-immunoprecipitated by an anti-HA antibody (<a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3<em>A</em></a>, <em>middle</em>). No significant immunoprecipitation of either protein was observed when expressed in the absence of each other. Consistent
                     with the preceding experiments, levels of APOBEC3G were reduced when APOBEC3G was coexpressed with Vif (<a id="xref-fig-3-3" class="xref-fig" href="#F3">Fig. 3<em>A</em></a>, <em>bottom</em>). We also performed experiments with purifed recombinant proteins to determine whether Vif and APOBEC3G can interact directly.
                     APOBEC3G was precipitated with GST-Vif but not GST or the truncated GST-Vif-(40–160) (<a id="xref-fig-3-4" class="xref-fig" href="#F3">Fig. 3<em>B</em></a>). These results suggest that Vif and APOBEC3G interact directly and form a complex <em>in vivo</em>, which accelerates the degradation of APOBEC3G via the ubiquitin-proteasome pathway.
                  </p>
                  <div id="F3" class="fig pos-float odd">
                     <div class="fig-inline"><a href="http://www.jbc.org/content/279/9/7792/F3.expansion.html"><img alt="Fig. 3." src="F3.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="http://www.jbc.org/content/279/9/7792/F3.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="http://www.jbc.org/content/279/9/7792/F3.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="http://www.jbc.org/powerpoint/279/9/7792/F3">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">F<span class="sc">ig</span>. 3.</span> 
                        <p id="p-23" class="first-child"><strong>Co-immunoprecipitation of Vif and APOBEC3.</strong> <em>A</em>, Vif and APOBEC3G were expressed in 293T cells as in <a id="xref-fig-1-16" class="xref-fig" href="#F1">Fig. 1<em>A</em></a>. Vif and APOBEC3G were immunoprecipitated with anti-Vif and anti-HA antibodies, respectively. Immunoprecipitates were detected
                           by Western blot (<em>top</em> and <em>middle</em>). Vif and APOBEC3G expression in cell lysates was confirmed by Western blot (<em>bottom</em>). <em>B</em>, recombinant APOBEC3G was incubated with recombinant GST, GST-Vif, or GST-Vif-(40–160) bound to glutathione-Sepharose. APOBEC3G
                           was detected by anti-APOBEC3G Western blot, and GST proteins were detected by staining with Coomassie Blue.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <p id="p-22"></p>
                  <p id="p-24"><em>Proteasomal Degradation of Vif Is Enhanced by APOBEC3G—</em> To further investigate the relationship between Vif-dependent degradation of APOBEC3G and viral infectivity, we tested the
                     infectivity of WT and ΔVif virus produced in the presence of increasing amounts of APOBEC3G. Increasing expression of APOBEC3G
                     dramatically reduced the infectivity of ΔVif virus in a dose-dependent manner (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Fig. 4<em>A</em></a>) as previously reported (<a id="xref-ref-3-7" class="xref-bibr" href="#ref-3">3</a>). However, a smaller yet significant decrease in the infectivity of WT HIV-1 was also observed (<a id="xref-fig-4-2" class="xref-fig" href="#F4">Fig. 4<em>A</em></a>). Comparing APOBEC3G expression in 293T cells producing WT or ΔVif virus demonstrated lower levels of APOBEC3G in the presence
                     of the WT virus. Surprisingly, we found that steady-state levels of Vif were affected by APOBEC3G expression. High expression
                     of APOBEC3G caused a significant reduction in Vif levels in parallel with a reduction in the infectivity of WT virus (<a id="xref-fig-4-3" class="xref-fig" href="#F4">Fig. 4<em>A</em></a>). These data suggest a reciprocal relationship wherein Vif and APOBEC3G influence the steady-state levels of each other.
                  </p>
                  <div id="F4" class="fig pos-float odd">
                     <div class="fig-inline"><a href="http://www.jbc.org/content/279/9/7792/F4.expansion.html"><img alt="Fig. 4." src="F4.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="http://www.jbc.org/content/279/9/7792/F4.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="http://www.jbc.org/content/279/9/7792/F4.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="http://www.jbc.org/powerpoint/279/9/7792/F4">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">F<span class="sc">ig</span>. 4.</span> 
                        <p id="p-26" class="first-child"><strong>Vif is polyubiquitinated and degraded by the proteasome in the presence of APOBEC3G.</strong> <em>A</em>, WT (▪) and ΔVif viruses (□) were produced in 293T cells co-transfected with provirus (3 μg) and increasing amounts of APOBEC3G
                           (0, 0.01, 0.02, 0.05, 0.1, or 0.2 μg) adjusted with an empty vector to 4 μg total. Infectivity was measured on the Cf2-luc
                           reporter cell line. The infectivity of each virus produced in the absence of APOBEC3G was normalized to 100%. APOBEC3G and
                           Vif were detected by Western blot of lysates from virus-producing cells. Data are representative of three independent experiments.
                           <em>B</em>, 293T cells were transfected with pNLA1.Vif-FLAG (10 μg) and mycUb (5 μg) or HAUb (5 μg), and cell lysates were immunoprecipitated
                           with anti-FLAG antibody and then subjected to anti-Vif (<em>top left</em>) or anti-HA (<em>top right</em>) Western blot. Monoubiquitinated Vif is indicated. Vif-FLAG was expressed with untagged WT or K48R Ub in the presence (<em>bottom right</em>) or absence (<em>bottom left</em>) of MG132/β-lactone. Tubulin was detected by Western blot with an anti-tubulin antibody. <em>C</em>, APOBEC3G, Vif-FLAG, mycUb, or the mutant mycUbK48R was expressed in 293T as in <a id="xref-fig-2-11" class="xref-fig" href="#F2">Fig. 2<em>B</em></a>. Following anti-FLAG immunoprecipitation, Vif and Ub-Vif were detected by Western blot with anti-Vif or anti-myc, respectively.
                           Monoubiquitinated and polyubiquitinated Vif are indicated. <em>D</em>, the half-life of Vif was determined by pulse-chase metabolic labeling in the presence (♦) or absence (▪) of APOBEC3G as
                           described under “Experimental Procedures.” Vif was immunoprecipitated with anti-Vif serum and quantitated by phosphorimaging
                           analysis. Protein levels were normalized to <em>t</em><sub>0</sub> = 100%. Results are representative of four independent experiments.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <p id="p-25"></p>
                  <p id="p-27">To investigate the mechanism by which APOBEC3G decreases the steady-state levels of Vif, we examined whether Vif is ubiquitinated.
                     A higher molecular mass 32-kDa form of Vif was observed in transfected 293T cells (Figs. <a id="xref-fig-1-17" class="xref-fig" href="#F1">1<em>A</em></a> and <a id="xref-fig-4-4" class="xref-fig" href="#F4">4<em>B</em></a>). The ∼8-kDa increase in size suggested covalent modification by ubiquitin. Coexpression of Vif with epitope-tagged ubiquitin
                     resulted in a shift in size of the higher molecular weight form (<a id="xref-fig-4-5" class="xref-fig" href="#F4">Fig. 4<em>B</em></a>, <em>top left</em>). Western blotting of immunoprecipitated Vif with an antibody that recognizes the HA epitope tag on ubiquitin confirmed that
                     Vif is covalently modified by the attachment of ubiquitin (<a id="xref-fig-4-6" class="xref-fig" href="#F4">Fig. 4<em>B</em></a>, <em>top right</em>). In the absence of APOBEC3G, the predominant ubiquitinated species of Vif appeared to be modified by monoubiquitin (<a id="xref-fig-4-7" class="xref-fig" href="#F4">Fig. 4<em>B</em></a>, <em>top</em>, data not shown). The chain-terminating mutant Ub<sub>K48R</sub> had no effect on the ubiquitination profile of Vif, consistent with a monoubiquitinated species (<a id="xref-fig-4-8" class="xref-fig" href="#F4">Fig. 4<em>B</em></a>, <em>bottom</em>). Furthermore, treatment of cells with proteasome inhibitors failed to substantially increase the levels of ubiquitinated
                     Vif (<a id="xref-fig-4-9" class="xref-fig" href="#F4">Fig. 4<em>B</em></a>, <em>bottom</em>). These results demonstrate that in the absence of APOBEC3G a minor fraction of Vif is monoubiquitinated. In the presence
                     of APOBEC3G, however, the amount of monoubiquitinated Vif was increased (<a id="xref-fig-4-10" class="xref-fig" href="#F4">Fig. 4<em>C</em></a>). Furthermore, we observed a dramatic increase in polyubiquitinated Vif when APOBEC3G was present. Coexpression of Vif and
                     APOBEC3G with the mutant Ub<sub>K48R</sub> showed increased amounts of ubiquitinated Vif compared with that observed with WT ubiquitin (<a id="xref-fig-4-11" class="xref-fig" href="#F4">Fig. 4<em>C</em></a>). We next examined the effects of APOBEC3G on the half-life of Vif. Pulse-chase metabolic labeling showed that Vif is a relatively
                     stable protein with a half-life of ∼90 min (<a id="xref-fig-4-12" class="xref-fig" href="#F4">Fig. 4<em>D</em></a>). However, in the presence of APOBEC3G the half-life of Vif decreased to approximately 23 min. Taken together, these results
                     indicate that coexpression of APOBEC3G promotes polyubiquitination and proteasomal degradation of a fraction of Vif. Thus,
                     Vif and APOBEC3G demonstrate an interdependent relationship in which both proteins promote the ubiquitination and degradation
                     of each other.
                  </p>
               </div>
               <div class="section" id="sec-4">
                  <div class="section-nav"><a href="#sec-3" title="RESULTS" class="prev-section-link"><span>Previous Section</span></a><a href="#ack-1" title="Acknowledgments" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>DISCUSSION</h2>
                  <p id="p-28">APOBEC3G is a DNA-editing enzyme with antiviral activity that is overcome by Vif (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>–<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>, <a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>). Vif blocks the encapsidation of APOBEC3G into HIV-1 virions (<a id="xref-ref-6-4" class="xref-bibr" href="#ref-6">6</a>), but the mechanism of action by which this occurs is unclear. Here we report that Vif counteracts APOBEC3G by targeting
                     it to the ubiquitin pathway for proteasome-mediated degradation. Vif forms a complex with APOBEC3G through a direct physical
                     interaction and enhances APOBEC3G ubiquitination, resulting in destabilization of APOBEC3G. Vif accelerates the degradation
                     of both ectopically expressed and endogenous APOBEC3G and recently has been shown to deplete APOBEC3G levels in HIV-1-infected
                     cells (<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>). The Vif mutants C114S/C133S and Δ142–154 that cannot support infection fail to induce degradation of APOBEC3G. Mutation
                     of the Thr<sup>96</sup> and Ser<sup>144</sup> phosphorylation sites within Vif impairs viral replication (<a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>) but does not affect APOBEC3G degradation, suggesting that Vif may be important for other functions in addition to inducing
                     degradation of APOBEC3G by the proteasome. These findings suggest that the primary mechanism of action by which Vif neutralizes
                     APOBEC3G is by promoting its degradation via the ubiquitin-proteasome pathway, thereby blocking its incorporation into virions.
                     However, our results also imply that an additional mode of action, such as APOBEC3G binding and sequestration, leading to
                     the inhibition of APOBEC3G incorporation into virions (<a id="xref-ref-8-7" class="xref-bibr" href="#ref-8">8</a>) or the recruitment of APOBEC3G away from sites of virus assembly may contribute to the functional activity of Vif and the
                     generation of infectious virus.
                  </p>
                  <p id="p-29">Ubiquitination is a tightly regulated cellular mechanism that can control the activity, localization, and turnover rates of
                     many cellular proteins (<a id="xref-ref-27-3" class="xref-bibr" href="#ref-27">27</a>). The ubiquitin machinery consists of an enzyme cascade that activates ubiquitin and ultimately transfers it to target proteins.
                     An E1 ubiquitin-activating enzyme transfers ubiquitin to an E2 ubiquitin-conjugating enzyme. Ubiquitin can then be directly
                     conjugated to a protein substrate by the E2, but more commonly an E3 ubiquitin ligase is required to covalently attach ubiquitin
                     to the ϵ-amino group of a lysine residue on the substrate. The E3 ubiquitin ligase conveys the exquisite targeting specificity
                     of the ubiquitination machinery. Vif forms a complex with and accelerates the ubiquitination and degradation of a population
                     of APOBEC3G, raising the possibility that Vif may directly ubiquitinate APOBEC3G. However, Vif has no sequence homology to
                     known E3 enzymes. Furthermore, Vif does not appear to have intrinsic ubiquitin ligase activity, because attempts to reconstitute
                     APOBEC3G degradation <em>in vitro</em> using Vif and purified components of the ubiquitin machinery were unsuccessful.<sup>2</sup> Therefore, it seems unlikely that Vif is the enzyme directly responsible for APOBEC3G ubiquitination. This was confirmed
                     by the recent work of Yu <em>et al.</em> (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>), which demonstrated that Vif function is dependent on the enzymatic activity of the ElonginB-ElonginC-Cullin5 ubiquitin
                     ligase complex and suggested that Vif may function as an F-box-like protein by acting as the specificity factor that links
                     APOBEC3G to the ElonginB-ElonginC-Cullin5 complex. We found that Vif is monoubiquitinated in the absence of APOBEC3G, although
                     monoubiquitination of Vif does not appear to target the protein for degradation. Rather, monoubiquitination may affect its
                     structure, location, or activity (<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>). We previously demonstrated that mutation of lysines within the Vif C terminus disrupts membrane targeting of Vif and virus
                     infectivity (<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>). Whether these lysines serve as ubiquitin conjugation sites remains to be determined. On expression of APOBEC3G a fraction
                     of Vif is polyubiquitinated and rapidly degraded; thus, coexpression of APOBEC3G and Vif decreases the stability of both proteins.
                     This finding, together with the observation that Vif and APOBEC3G form a complex <em>in vitro</em> and <em>in vivo</em> (<a id="xref-fig-3-5" class="xref-fig" href="#F3">Fig. 3</a>) and the demonstration that Vif mutants that fail to bind APOBEC3G do not decrease APOBEC3G levels (<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>), raises the possibility that these two proteins may be coordinately degraded as a complex. However, further studies are
                     required to determine whether Vif and APOBEC3G are degraded within the same complex or independently.
                  </p>
                  <p id="p-30">Our findings suggest that the ratio between Vif and APOBEC3G is crucial for maximal effects of Vif on APOBEC3G degradation
                     and viral infectivity. In infected cells, Vif is expressed at high levels, approaching those of Gag (<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>). In contrast, APOBEC3G appears to be expressed at very low levels in non-permissive cells (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">19</a>). Thus, it appears that HIV-1 conquers the cellular defenses of APOBEC3G by expressing the high levels of Vif that are needed
                     to achieve a Vif:APOBEC3G ratio that leads to APOBEC3G degradation. A difference in Vif: APOBEC3G ratios may explain why our
                     results differ from those previously reported by Mariani <em>et al.</em> (<a id="xref-ref-8-8" class="xref-bibr" href="#ref-8">8</a>), who reported that Vif had no significant effect on the steady-state levels or half-life of APOBEC3G. While this manuscript
                     was under review, other studies were published that support our findings of a Vif-dependent decrease in APOBEC3G half-life
                     and steady-state levels (<a id="xref-ref-19-4" class="xref-bibr" href="#ref-19">19</a>, <a id="xref-ref-30-2" class="xref-bibr" href="#ref-30">30</a>, <a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a>, <a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>). Compared with these studies, our study reaches the novel conclusion that there is a reciprocal destabilizing relationship
                     between Vif and APOBEC3G because coexpression of APOBEC3G promotes Vif ubiquitination and reduces its half-life. These results
                     differ from those reported by Stopak <em>et al.</em> (<a id="xref-ref-19-5" class="xref-bibr" href="#ref-19">19</a>) and Marin <em>et al.</em> (<a id="xref-ref-33-3" class="xref-bibr" href="#ref-33">33</a>) who did not observe that APOBEC3G destabilizes Vif. These discrepancies may be the result of differences in the ratio of
                     APOBEC3G:Vif, which strongly influences the ability to detect this phenomenon. Furthermore, we performed experiments to determine
                     the effect of APOBEC3G on the half-life and ubiquitination of Vif, whereas these other studies did not. Whether the levels
                     of APOBEC3G used in <a id="xref-fig-4-13" class="xref-fig" href="#F4">Fig. 4</a> are ever approached <em>in vivo</em> during certain conditions that increase APOBEC3G expression, such as mitogenic stimulation (<a id="xref-ref-19-6" class="xref-bibr" href="#ref-19">19</a>), remains to be determined. Nonetheless, we observed that only a fraction of Vif is ubiquitinated and destabilized by coexpression
                     of APOBEC3G, possibly because of limiting amounts of APOBEC3G expressed in these cells or the differential localization of
                     a fraction of both proteins.
                  </p>
                  <p id="p-31">In the absence of Vif, we found that APOBEC3G has a relatively short half-life of only 29 min during its early phase of decay.
                     The half-life of APOBEC3G is highly dependent on its level of expression; but in the absence of Vif, the half-life of APOBEC3G
                     increases to around 50 min or 5–6 h when we transfect 0.5 or 5 μg, respectively, of pAPOBEC3G:HA plasmid instead of 0.1 μg.<sup>2</sup> Endogenous APOBEC3G is expressed at very low levels (<a id="xref-ref-19-7" class="xref-bibr" href="#ref-19">19</a>), so its half-life is expected to be short under physiological conditions. Given the editing capabilities of APOBEC3G, its
                     rapid turnover may represent a cellular mechanism to tightly regulate the expression of a potential DNA mutator. Inducing
                     expression of APOBEC3G might bolster the antiviral response and decrease the production of infectious virus but may also be
                     deleterious to the overall fitness of the cell. For example, unregulated expression of the related cytidine deaminase APOBEC1
                     is oncogenic in animal models (<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>). APOBEC3G displayed a biphasic decay characterized by rapid degradation in the early phase followed by slow degradation
                     during the late phase. The biphasic decay could be because of differential degradation of APOBEC3G populations localized to
                     distinct compartments within the cell. The majority of APOBEC3G is cytoplasmic with a minor fraction localized to the nucleus
                     (<a id="xref-ref-19-8" class="xref-bibr" href="#ref-19">19</a>). Vif, a cytoplasmic protein, was capable of reducing the half-life of APOBEC3G only during early phase decay, consistent
                     with our finding that high levels of Vif did not induce complete degradation of APOBEC3G. Nonetheless, virus with full infectivity
                     was produced. Thus, there appears to be a population of APOBEC3G that is resistant to Vif-dependent degradation and does not
                     influence viral infectivity. Whether this represents the nuclear fraction or a cytoplasmic fraction localized away from sites
                     of virus assembly remains to be determined.
                  </p>
                  <p id="p-32">We propose that Vif functions as an adaptor molecule, recruiting APOBEC3G to the ubiquitin-proteasome machinery. Other viral
                     proteins are known to subvert the ubiquitination machinery by a similar mechanism. The papillomavirus E6 oncoprotein bridges
                     the tumor suppressor p53 to the ubiquitin ligase E6-AP (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>). The HIV-1 Vpu protein scaffolds a ternary complex with CD4 and the E3 βTrCP (<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>). Cellular proteins can also function in an analogous manner with Grb10 recruiting insulin-like growth factor I receptor
                     to the Nedd4 ubiquitin ligase (<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>). In each case, target proteins are recruited to the ubiquitin machinery by their cognate adaptor, polyubiquitinated, and
                     degraded by the proteasome. Unlike Vif, however, neither E6, Vpu, nor Grb10 is ubiquitinated and degraded on coexpression
                     of the target protein. The interaction between Vif, APOBEC3G, and the ubiquitin machinery implicates the proteasome as a site
                     of dynamic interplay between viral and host defenses and provides a new interface for pharmaceutical intervention.
                  </p>
               </div>
               <div class="section ack" id="ack-1">
                  <div class="section-nav"><a href="#sec-4" title="DISCUSSION" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Acknowledgments</h2>
                  <p id="p-35">We thank K. Strebel, H. Gottlinger, W. Greene, and M. Malim for reagents, J. Skaar, H. Wilson, and E. Thomas for technical
                     assistance, and A. Engleman, A. Goldberg, N. Madani, A. Calistri, and J. Sodroski for helpful discussions.
                  </p>
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#ack-1" title="Acknowledgments" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn" id="fn-1">
                        <p id="p-4"><a class="rev-xref" href="#xref-fn-1-1">↵</a><span class="fn-label">1</span> The abbreviations used are: HIV, human immunodeficiency virus; Vif, virion infectivity factor; ΔVif, Vif-defective viruses;
                           WT, wild type; GST, glutathione <em>S</em>-transferase; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase; HA, hemagglutinin.
                        </p>
                     </li>
                     <li class="fn" id="fn-2">
                        <p id="p-18"><a class="rev-xref" href="#xref-fn-2-1">↵</a><span class="fn-label">2</span> A. Mehle and D. Gabuzda, unpublished observations.
                        </p>
                     </li>
                     <li class="fn fn-group-arthw-misc" id="fn-3">
                        <p id="p-33"><a class="rev-xref" href="#xref-fn-3-1">↵</a><span class="fn-label">*</span> This work was supported by National Institutes of Health Grant AI36186 and a grant from The American Foundation for AIDS
                           Research. Core facilities were supported by a Center for AIDS Research Grant (AI28691) and the Dana-Farber Cancer Institute/Harvard
                           Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article
                           must therefore be hereby marked “<em>advertisement</em>” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
                        </p>
                     </li>
                     <li class="fn fn-group-arthw-misc" id="fn-4">
                        <p id="p-34"><a class="rev-xref" href="#xref-fn-4-1">↵</a><span class="fn-label">¶</span> Supported in part by a National Science Foundation Predoctoral Fellowship.
                        </p>
                     </li>
                  </ul>
               </div>
               <ul class="history-list">
                  <li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="2003-10-30"><span class="received-label">Received </span>October 30, 2003.
                  </li>
                  <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd" hwp:start="2003-12-01"><span class="rev-recd-label">Revision received </span>December 1, 2003.
                  </li>
               </ul>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">The American Society for Biochemistry and Molecular Biology, Inc.</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder">&nbsp;</div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list">
                     <li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.1">
                           <div class="cit-metadata"><cite>Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R. C., and Wong-Staal, F. (<span class="cit-pub-date">1987</span>) <span class="cit-source">Science</span> <span class="cit-vol">237</span>, <span class="cit-fpage">888</span>–893</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=237/4817/888" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.2">
                           <div class="cit-metadata"><cite>Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., and Martin, M. A. (<span class="cit-pub-date">1987</span>) <span class="cit-source">Nature</span> <span class="cit-vol">328</span>, <span class="cit-fpage">728</span>–730</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/328728a0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=2441266&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.3">
                           <div class="cit-metadata"><cite>Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (<span class="cit-pub-date">2002</span>) <span class="cit-source">Nature</span> <span class="cit-vol">418</span>, <span class="cit-fpage">646</span>–650</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/nature00939&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12167863&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.4">
                           <div class="cit-metadata"><cite>Harris, R. S., Sheehy, A. M., Craig, H. M., Malim, M. H., and Neuberger, M. S. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Nat. Immunol.</span> <span class="cit-vol">4</span>, <span class="cit-fpage">641</span>–643</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/ni0703-641&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12830140&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.5">
                           <div class="cit-metadata"><cite>Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A. J. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Science</span> <span class="cit-vol">300</span>, <span class="cit-fpage">1112</span></cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=FULL&amp;journalCode=sci&amp;resid=300/5622/1112" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.6">
                           <div class="cit-metadata"><cite>Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Nature</span> <span class="cit-vol">424</span>, <span class="cit-fpage">99</span>–103</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/nature01709&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12808466&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.7">
                           <div class="cit-metadata"><cite>Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Nature</span> <span class="cit-vol">424</span>, <span class="cit-fpage">94</span>–98</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/nature01707&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12808465&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.8">
                           <div class="cit-metadata"><cite>Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H., and Landau, N.
                                 R. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Cell</span> <span class="cit-vol">114</span>, <span class="cit-fpage">21</span>–31</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/S0092-8674(03)00515-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12859895&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.9">
                           <div class="cit-metadata"><cite>Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim,
                                 M. H. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Cell</span> <span class="cit-vol">113</span>, <span class="cit-fpage">803</span>–809</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/S0092-8674(03)00423-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=12809610&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.10">
                           <div class="cit-metadata"><cite>von Schwedler, U., Song, J., Aiken, C., and Trono, D. (<span class="cit-pub-date">1993</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">67</span>, <span class="cit-fpage">4945</span>–4955</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=67/8/4945" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.11">
                           <div class="cit-metadata"><cite>Vartanian, J. P., Meyerhans, A., Asjo, B., and Wain-Hobson, S. (<span class="cit-pub-date">1991</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">65</span>, <span class="cit-fpage">1779</span>–1788</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=65/4/1779" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.12">
                           <div class="cit-metadata"><cite>Vartanian, J. P., Meyerhans, A., Sala, M., Wain-Hobson, S., Borman, A. M., Quillent, C., Charneau, P., Kean, K. M., and Clavel,
                                 F. (<span class="cit-pub-date">1994</span>) <span class="cit-source">Proc. Natl. Acad. Sci. U. S. A.</span> <span class="cit-vol">91</span>, <span class="cit-fpage">3092</span>–3096</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/8/3092" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.13">
                           <div class="cit-metadata"><cite>Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., and Sodroski, J. (<span class="cit-pub-date">1992</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">66</span>, <span class="cit-fpage">6489</span>–6495</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=66/11/6489" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.14">
                           <div class="cit-metadata"><cite>Sakai, H., Shibata, R., Sakuragi, J., Sakuragi, S., Kawamura, M., and Adachi, A. (<span class="cit-pub-date">1993</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">67</span>, <span class="cit-fpage">1663</span>–1666</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=67/3/1663" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.15">
                           <div class="cit-metadata"><cite>Goncalves, J., Korin, Y., Zack, J., and Gabuzda, D. (<span class="cit-pub-date">1996</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">70</span>, <span class="cit-fpage">8701</span>–8709</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=70/12/8701" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.16">
                           <div class="cit-metadata"><cite>Simon, J. H., and Malim, M. H. (<span class="cit-pub-date">1996</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">70</span>, <span class="cit-fpage">5297</span>–5305</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=70/8/5297" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.17">
                           <div class="cit-metadata"><cite>Blanc, D., Patience, C., Schulz, T. F., Weiss, R., and Spire, B. (<span class="cit-pub-date">1993</span>) <span class="cit-source">Virology</span> <span class="cit-vol">193</span>, <span class="cit-fpage">186</span>–192</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1006/viro.1993.1114&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=8438565&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.18">
                           <div class="cit-metadata"><cite>Goncalves, J., Jallepalli, P., and Gabuzda, D. H. (<span class="cit-pub-date">1994</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">68</span>, <span class="cit-fpage">704</span>–712</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=68/2/704" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.19">
                           <div class="cit-metadata"><cite>Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Mol. Cell</span> <span class="cit-vol">12</span>, <span class="cit-fpage">591</span>–601</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/S1097-2765(03)00353-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=14527406&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.20">
                           <div class="cit-metadata"><cite>Brown, H. E., Chen, H., and Engelman, A. (<span class="cit-pub-date">1999</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">73</span>, <span class="cit-fpage">9011</span>–9020</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=73/11/9011" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.21">
                           <div class="cit-metadata"><cite>Yang, X., Goncalves, J., and Gabuzda, D. (<span class="cit-pub-date">1996</span>) <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">271</span>, <span class="cit-fpage">10121</span>–10129</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=271/17/10121" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.22">
                           <div class="cit-metadata"><cite>Ward, C. L., Omura, S., and Kopito, R. R. (<span class="cit-pub-date">1995</span>) <span class="cit-source">Cell</span> <span class="cit-vol">83</span>, <span class="cit-fpage">121</span>–127</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/0092-8674(95)90240-6&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=7553863&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.23">
                           <div class="cit-metadata"><cite>Ohagen, A., and Gabuzda, D. (<span class="cit-pub-date">2000</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span>, <span class="cit-fpage">11055</span>–11066</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/23/11055" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.24">
                           <div class="cit-metadata"><cite>Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., and Gabuzda, D. (<span class="cit-pub-date">2003</span>) <span class="cit-source">J. Exp. Med.</span> <span class="cit-vol">197</span>, <span class="cit-fpage">1701</span>–1707</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=197/12/1701" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.25">
                           <div class="cit-metadata"><cite>Ma, X. Y., Sova, P., Chao, W., and Volsky, D. J. (<span class="cit-pub-date">1994</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">68</span>, <span class="cit-fpage">1714</span>–1720</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=68/3/1714" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.26">
                           <div class="cit-metadata"><cite>Yang, X., and Gabuzda, D. (<span class="cit-pub-date">1998</span>) <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">273</span>, <span class="cit-fpage">29879</span>–29887</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/45/29879" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.27">
                           <div class="cit-metadata"><cite>Ulrich, H. D. (<span class="cit-pub-date">2002</span>) <span class="cit-source">Curr. Top. Microbiol. Immunol.</span> <span class="cit-vol">268</span>, <span class="cit-fpage">137</span>–174</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=12083004&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.28">
                           <div class="cit-metadata"><cite>Finley, D., Sadis, S., Monia, B. P., Boucher, P., Ecker, D. J., Crooke, S. T., and Chau, V. (<span class="cit-pub-date">1994</span>) <span class="cit-source">Mol. Cell. Biol.</span> <span class="cit-vol">14</span>, <span class="cit-fpage">5501</span>–5509</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=mcb&amp;resid=14/8/5501" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.29">
                           <div class="cit-metadata"><cite>Tsirigotis, M., Zhang, M., Chiu, R. K., Wouters, B. G., and Gray, D. A. (<span class="cit-pub-date">2001</span>) <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">276</span>, <span class="cit-fpage">46073</span>–46078</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=276/49/46073" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30 in text" id="ref-30">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.30">
                           <div class="cit-metadata"><cite>Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Science</span> <span class="cit-vol">302</span>, <span class="cit-fpage">1056</span>–1060</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=302/5647/1056" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31 in text" id="ref-31">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.31">
                           <div class="cit-metadata"><cite>Hicke, L. (<span class="cit-pub-date">2001</span>) <span class="cit-source">Nat. Rev. Mol. Cell Biol.</span> <span class="cit-vol">2</span>, <span class="cit-fpage">195</span>–201</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/35056583&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=11265249&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32 in text" id="ref-32">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.32">
                           <div class="cit-metadata"><cite>Goncalves, J., Shi, B., Yang, X., and Gabuzda, D. (<span class="cit-pub-date">1995</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span>, <span class="cit-fpage">7196</span>–71204</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/11/7196" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33 in text" id="ref-33">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.33">
                           <div class="cit-metadata"><cite>Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Nat. Med.</span> <span class="cit-vol">9</span>, <span class="cit-fpage">1398</span>–1403</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/nm946&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=14528301&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34 in text" id="ref-34">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.34">
                           <div class="cit-metadata"><cite>Fouchier, R. A., Simon, J. H., Jaffe, A. B., and Malim, M. H. (<span class="cit-pub-date">1996</span>) <span class="cit-source">J. Virol.</span> <span class="cit-vol">70</span>, <span class="cit-fpage">8263</span>–8269</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=70/12/8263" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35 in text" id="ref-35">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.35">
                           <div class="cit-metadata"><cite>Sheehy, A. M., Gaddis, N. C., and Malim, M. H. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Nat. Med.</span> <span class="cit-vol">9</span>, <span class="cit-fpage">1404</span>–1407</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1038/nm945&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=14528300&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36 in text" id="ref-36">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.36">
                           <div class="cit-metadata"><cite>Yamanaka, S., Balestra, M., Ferrell, L., Fan, J., Arnold, K., Taylor, S., Taylor, J., and Innerarity, T. (<span class="cit-pub-date">1995</span>) <span class="cit-source">Proc. Natl. Acad. Sci. U. S. A.</span> <span class="cit-vol">92</span>, <span class="cit-fpage">8483</span>–8487</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=92/18/8483" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37 in text" id="ref-37">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.37">
                           <div class="cit-metadata"><cite>Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. (<span class="cit-pub-date">1993</span>) <span class="cit-source">Cell</span> <span class="cit-vol">75</span>, <span class="cit-fpage">495</span>–505</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/0092-8674(93)90384-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=8221889&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38 in text" id="ref-38">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.38">
                           <div class="cit-metadata"><cite>Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. (<span class="cit-pub-date">1998</span>) <span class="cit-source">Mol. Cell</span> <span class="cit-vol">1</span>, <span class="cit-fpage">565</span>–574</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/external-ref?access_num=10.1016/S1097-2765(00)80056-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://www.jbc.org/external-ref?access_num=9660940&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39 in text" id="ref-39">↵</a><div class="cit ref-cit ref-other" id="cit-279.9.7792.39">
                           <div class="cit-metadata"><cite>Vecchione, A., Marchese, A., Henry, P., Rotin, D., and Morrione, A. (<span class="cit-pub-date">2003</span>) <span class="cit-source">Mol. Cell. Biol.</span> <span class="cit-vol">23</span>, <span class="cit-fpage">3363</span>–3372</cite></div>
                           <div class="cit-extra"><a href="http://www.jbc.org/cgi/ijlink?linkType=ABST&amp;journalCode=mcb&amp;resid=23/9/3363" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div class="social-bookmarking">
               
               <ul class="social-bookmark-links">
                  <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/short/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-linkedin"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=LINKEDIN"><img src="linkedin.gif" alt="Add to LinkedIn" title="LinkedIn"></a><span class="soc-bm-link-text">LinkedIn</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
               </ul>
               
               <p class="social-bookmarking-help"><a href="http://www.jbc.org/help/social_bookmarks.dtl">What's this?</a></p>
               
            </div><span id="related-urls"></span></div>
         <div class="spanned" style="height: 11959px;" id="col-2">
            			
            			
            <div class="col-span">
               
               <ul>
                  <li><a href="http://affinity.jbc.org/"><img src="Affinity_Site_landing_page_link_art_for_article_view_400x125.gif"></a></li>
               </ul>
               
            </div>
            			
            <div class="article-nav sidebar-nav">
               <a href="http://www.jbc.org/content/279/9/7785.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="http://www.jbc.org/content/279/9/7799.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="http://www.jbc.org/content/279/9.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              		<span class="slug-metadata-note ahead-of-print">

                                 	
                                 First Published on
                                 
                                 <span class="slug-ahead-of-print-date">December 13, 2003</span>,
                                 doi:
                                 <span title="10.1074/jbc.M313093200" class="slug-doi">10.1074/jbc.M313093200
                                    </span>
                                 </span>
                              
                              <cite>
                                 	    <span class="slug-pub-date" itemprop="datePublished">

                                    	    February 27, 2004 
                                    </span><abbr title="The Journal of Biological Chemistry" class="slug-jnl-abbrev">

                                    The Journal of Biological Chemistry,</abbr>
                                 	    <span class="slug-vol">

                                    279, 
                                    </span><span class="slug-pages">

                                    7792-7798.
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="http://www.jbc.org/content/279/9/7792.abstract" rel="view-abstract">Abstract</a><span class="viewspecificaccesscheck jbc;279/9/7792 abstract"></span></li>
                        <li class="notice full-text-view-link primary"><span class="variant-indicator">» <span>Full Text</span></span><span class="viewspecificaccesscheck jbc;279/9/7792 full"></span></li>
                        <li class="notice full-text-pdf-view-link primary"><a href="http://www.jbc.org/content/279/9/7792.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="viewspecificaccesscheck jbc;279/9/7792 reprint"></span></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="http://www.jbc.org/content/early/2003/12/13/jbc.M313093200">M313093200v1</a></li>
                                 <li class="current-li"><span>279/9/7792</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Classifications</span></a></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search" href="http://www.jbc.org/search?tocsectionid=Protein+Synthesis%2C+Post-Translation+Modification%2C+and+Degradation&amp;sortspec=date&amp;submit=Submit">Protein Synthesis, Post-Translation Modification, and Degradation</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Services</span></a></h4>
                     <ol>
                        <li class="mail-a-friend-link icon-link"><a href="http://www.jbc.org/email?gca=jbc;279/9/7792&amp;current-view-path=/content/279/9/7792.full">

                              Email this article to a friend</a></li>
                        <li class="alert-link icon-link"><a href="http://www.jbc.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jbc;279/9/7792&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://www.jbc.org/content/279/9/7792.full">Alert me when this article is cited</a></li>
                        <li class="alert-link icon-link"><a href="http://www.jbc.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=279/9/7792&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://www.jbc.org/content/279/9/7792.full">Alert me if a correction is posted</a></li>
                        <li class="alert-link eletter-alert-link icon-link"><a href="http://www.jbc.org/cgi/alerts/ctalert?alertType=eletter&amp;addAlert=eletter&amp;eletter_criteria_value=279/9/7792&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://www.jbc.org/content/279/9/7792.full">Alert me when eletters are published</a></li>
                        <li class="similar-link"><a href="http://www.jbc.org/search?qbe=jbc;M313093200&amp;citation=Mehle%20et%20al.%20279%20%289%29:%207792&amp;submit=yes">Similar articles in this journal</a></li>
                        <li class="similar-link"><a href="http://www.jbc.org/external-ref?access_num=jbc%3B279%2F9%2F7792&amp;link_type=ISI_RELATEDRECORDS" id="cb-isi-similar-articles" class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="http://www.jbc.org/external-ref?access_num=14672928&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="http://www.jbc.org/citmgr?gca=jbc;279/9/7792">Download to citation manager</a></li>
                        <li class="copyright-link icon-link"><a class="request-permissions" href="https://s100.copyright.com/AppDispatchServlet?publisherName=ASBMB&amp;publication=jbc&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway&amp;publicationDate=02/27/2004&amp;author=Andrew%20Mehle,%20Bettina%20Strack,%20Petronela%20Ancuta,%20Chengsheng%20Zhang,%20Mark%20McPike,%20Dana%20Gabuzda&amp;startPage=7792&amp;contentID=10.1074/jbc.M313093200&amp;orderBeanReset=true&amp;endPage=7798&amp;volumeNum=279&amp;issueNum=9" target="_top">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-open" id="cb-letter-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Responses</span></a></h4>
                     <ol>
                        <li><a href="http://www.jbc.org/site/eLetters/index.xhtml">Submit a Letter to the Editor</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Citing Articles</span></a></h4>
                     <ol style="display: none;">
                        <li class="hw-citing-link"><a href="http://www.jbc.org/content/279/9/7792.full?cited-by=yes&amp;legid=jbc;279/9/7792#cited-by" id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a title="[opens in a new window]" target="_top" href="http://www.jbc.org/external-ref?access_num=%2Fjbc%2F279%2F9%2F7792&amp;link_type=ISI_CITING&amp;accnum_type=native" rel="external-nw" id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="http://www.jbc.org/external-ref?access_num=http://www.jbc.org/content/279/9/7792.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-gs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Google Scholar</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AMehle%20author%3AA.%22" class="cb-art-gs-auth author-link">Articles by  Mehle, A.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AGabuzda%20author%3AD.%22" class="cb-art-gs-auth author-link">Articles by  Gabuzda, D.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="http://www.jbc.org/external-ref?access_num=http://www.jbc.org/content/279/9/7792.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-pm">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>PubMed</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="http://www.jbc.org/external-ref?access_num=14672928&amp;link_type=PUBMED" class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://www.jbc.org/external-ref?access_num=Mehle%20A&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Mehle, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://www.jbc.org/external-ref?access_num=Gabuzda%20D&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Gabuzda, D.</a></li>
                        <li>
                           <div id="cb-entrez-links-placeholder"><a href="http://www.jbc.org/entrez-links/14672928"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-rel">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Related Content</span></a></h4>
                     <ol style="display: none;">
                        <li><a href="http://www.jbc.org/content/279/9/7792.full?related-urls=yes&amp;legid=jbc;279/9/7792#related-urls" id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed soc-links icon-link collapsed" id="cb-art-soc">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Social Bookmarking</span></a></h4>
                     <ol style="display: none;">
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/short/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-linkedin"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=LINKEDIN"><img src="linkedin.gif" alt="Add to LinkedIn" title="LinkedIn"></a><span class="soc-bm-link-text">LinkedIn</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/279/9/7792&amp;title=Vif%20Overcomes%20the%20Innate%20Antiviral%20Activity%20of%20APOBEC3G%20by%20Promoting%20Its%20Degradation%20in%20the%20Ubiquitin-Proteasome%20Pathway+--+Mehle%20et%20al.%20279%20%289%29%3A%207792+--+&amp;doi=10.1074/jbc.M313093200&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="http://www.jbc.org/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            			
            			
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-2">EXPERIMENTAL PROCEDURES</a></li>
                        <li><a href="#sec-3">RESULTS</a></li>
                        <li><a href="#sec-4">DISCUSSION</a></li>
                        <li><a href="#ack-1">Acknowledgments</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div class="future-space sb-div"></div>
            		
         </div>
         <div class="spanned" style="height: 11959px;" id="col-3"><div style="height: 85px;" class="col-span-holder"></div>
            			
            			
            			
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Week's Issue</span></h3>
                  <div class="cb-section">
                     <ol>
                        <li><span><a href="http://www.jbc.org/content/current" rel="current-issue">May 10, 2013, 288 (19)</a></span></li>
                     </ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li>
                           <div class="current-issue"><a href="http://www.jbc.org/content/current" rel="current-issue"><img src="19.cover.gif" alt="Current Issue" height="89" width="67"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="http://www.jbc.org/cgi/alerts/etoc">Alert me to new issues of JBC
                              </a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               
               
               <ul class="button-list pub-links">
                  <li class="first">
                     <a href="http://www.jbc.org/misc/itoa.xhtml" title="Authors">
                        <span>Authors</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://submit.jbc.org/" title="Submit">
                        <span>Submit</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/subscriptions/" title="Subscribers">
                        <span>Subscribers</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://apps.asbmb.org/jbcboard/default.aspx" onclick="window.open(this.href,'_blank');return false;" title="Editorial Board">
                        <span>Editorial Board</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/misc/edpolicy.xhtml" title="Editorial Policies">
                        <span>Editorial Policies</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/podcast/" title="JBC Podcasts">
                        <img alt="icon for JBC Podcasts" src="podcast_icon_200px.png" style="float: right;" width="20">
                        <span>JBC Podcasts</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.asbmb.org/video.aspx" onclick="window.open(this.href,'_blank');return false;" title="ASBMB videos">
                        <img alt="video icon" src="video_icon.png" style="float: right;" height="24">
                        <span>Videos</span>
                        </a>
                     
                  </li>
                  <li>
                     <span>Alerts &amp; Feeds</span>
                     <br>
                     <span>&nbsp;&nbsp;<a href="http://www.jbc.org/site/home/about/rss_alerts.xhtml" title="RSS and Email Alerts">
                           <img alt="icon for e-mail" src="email.gif" title="icon for e-mail" width="20">&nbsp;E-mail</a>
                        </span>
                     <br>
                     <span>&nbsp;&nbsp;<a href="http://www.jbc.org/site/home/about/rss_alerts.xhtml" title="RSS and Email Alerts">
                           <img alt="RSS icon" src="RSS.gif" title="RSS icon" width="20">&nbsp;RSS</a>
                        </span>
                     <br>
                     <span>&nbsp;&nbsp;<a href="http://www.twitter.com/jbiolchem" onclick="window.open(this.href,'_blank');return false;" title="Follow the JBC on Twitter">
                           <img alt="Twitter icon" src="twitter_001.gif" title="Twitter icon" width="20">&nbsp;Twitter</a>
                        </span>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/home/about/article_stats.xhtml" title="Article Statistics">
                        <span>Article Statistics</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/home/teaching_tools/" title="Teaching Tools">
                        <span>Teaching Tools</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/misc/Copyright_Permission.xhtml" title="Copyright Permissions">
                        <span>Copyright Permissions</span>
                        </a>
                     
                  </li>
                  <li>
                     <a href="http://www.jbc.org/site/misc/ASBMBjournals_MEDIAKIT.pdf" title="Advertise">
                        <span>Advertise</span>
                        </a>
                     
                  </li>
                  <li class="last">
                     <a href="http://www.jbc.org/cgi/feedback" title="Contact JBC">
                        <span>Contact JBC</span>
                        </a>
                     
                  </li>
               </ul>
               
               
            </div>
            			
            			
            		
         </div>
         <div id="footer">
            
            <div class="bar">
               	
               <div class="footer-group footer-col-left">
                  	  
                  
                  <div class="footer-group footer-col-left">
                     
                     <div class="copyright">
                        
                        <p>
                           <span>Copyright © 2013</span> by <a href="http://www.asbmb.org/">American Society for Biochemistry and Molecular Biology</a>
                           
                        </p>
                        
                        <p>
                           <a href="http://intl.jbc.org/">Alternate route to the JBC: http://intl.jbc.org</a>
                           
                        </p>
                        
                        <p>
                           <a href="http://www.jbc.org/cgi/feedback">Contact <abbr class="footer-contact">JBC</abbr>
                              </a> | <a href="http://www.jbc.org/help/">Help Pages</a>
                           
                        </p>
                        
                     </div>
                     
                     <ul class="footer_logos">
                        <li>
                           <a href="http://www.asbmb.org/page.aspx?id=218">
                              <img src="atoday_logo.gif" alt="asbmb_today_logo">
                              </a>
                           
                        </li>
                        <li>
                           <a href="http://www.jlr.org/">
                              <img src="jlr_logo.gif" alt="jlr_logo">
                              </a>
                           
                        </li>
                        <li>
                           <a href="http://mcponline.org/">
                              <img src="mcp_logo.gif" alt="mcp_logo">
                              </a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  	
               </div>
               	
               <div class="footer-group footer-col-right">
                  	  
                  <ul class="issns">
                     <li>
                        <span>Print ISSN</span>
                        <span class="issn">0021-9258</span>
                        
                     </li>
                     <li>
                        <span>Online ISSN</span>
                        <span class="issn">1083-351X</span>
                        
                     </li>
                  </ul>
                  	
               </div>
               
            </div>
            
            
            <div class="block-2 sb-div"></div>
            
         </div>
         <div id="ad-tower">
            
            <ul class="tower-ads">
               <li class="position-right1">
                  
                  <span class="ad-header">Advertisement</span>
                  <script language="JavaScript" type="text/javascript">

            //
            OAS_AD('Right1');
            //
          </script>
                  </li>
               <li class="position-right2">
                  <span class="ad-header">Advertisement</span>
                  <script language="JavaScript" type="text/javascript">

            //
            OAS_AD('Right2');
            //
          </script>
                  </li>
            </ul>
            
         </div>
         <div id="ad-footer">
            <span class="ad-header">Advertisement</span>
            <script language="JavaScript" type="text/javascript">

	//
	OAS_AD('Bottom');
	//
      </script>
            </div>
         <div id="ad-footer2">
            
            
            <ul></ul>
            
         </div><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-4790327-1");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   
<div id="fancybox-tmp"></div><div id="fancybox-loading"><div></div></div><div id="fancybox-overlay"></div><div id="fancybox-wrap"><div id="fancybox-outer"><div class="fancybox-bg" id="fancybox-bg-n"></div><div class="fancybox-bg" id="fancybox-bg-ne"></div><div class="fancybox-bg" id="fancybox-bg-e"></div><div class="fancybox-bg" id="fancybox-bg-se"></div><div class="fancybox-bg" id="fancybox-bg-s"></div><div class="fancybox-bg" id="fancybox-bg-sw"></div><div class="fancybox-bg" id="fancybox-bg-w"></div><div class="fancybox-bg" id="fancybox-bg-nw"></div><div id="fancybox-content"></div><a id="fancybox-close"></a><div id="fancybox-title"></div><a href="javascript:;" id="fancybox-left"><span class="fancy-ico" id="fancybox-left-ico"></span></a><a href="javascript:;" id="fancybox-right"><span class="fancy-ico" id="fancybox-right-ico"></span></a></div></div></body>
</html>
